The aim of the present work was to analyze whether on-admission serum albumin levels may predict the risk of <30 days in-hospital all-cause mortality in a cohort of COVID-19-infected patients who were hospitalized in public hospitals of the Madrid community (Spain), during the second wave of the COVID-19 pandemic. The gene discussed is ALB; the disease is COVID-19.